OpenLegislation

Section 3 Market surveillanceF1

United Kingdom Repealed

Original text. Later amendments are not shown.

  1. 93Market surveillance activities
  2. 94Evaluation of devices suspected of presenting an unacceptable risk or other non-compliance
  3. 95Procedure for dealing with devices presenting an unacceptable risk to health and safety
  4. 96Procedure for evaluating national measures at Union level
  5. 97Other non-compliance
  6. 98Preventive health protection measures
  7. 99Good administrative practice
  8. 100Electronic system on market surveillance

Annotations

Textual amendments

F1

Regulation revoked (31.12.2020) by The Medical Devices Regulations 2002 (S.I. 2002/618), reg. 4O (with savings and transitional provisions for N.I. in reg. 3ZA) (as amended by S.I. 2019/791, regs. 1(1), 3(7) and by S.I. 2020/1478, regs. 1(3), Sch. 2 para. 2; and as amended (27.7.2021) by The Medical Devices (Northern Ireland Protocol) Regulations 2021 (S.I. 2021/905), regs. 1(2), 4, 32); 2020 c. 1, Sch. 5 para. 1(1))